{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:28:42Z","timestamp":1788560922360,"version":"build-2803163510"},"reference-count":99,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Autoimmune disorders are destructive processes considered to be an attack on \u201cself \u201d antigens by the immune system CD-+4 T-cells that are directed toward antigens, in the case of multiple sclerosis (MS), particularly myelin antigens. Yet, there is growing evidence that the major destructive events in MS, as well as other non-central nervous system (CNS) autoimmune disorders, are much more than an immune attack on the CNS initiated by a misdirected immune system that attacks a \u201cself \u201d antigen or antigens by a process called molecular mimicry. Extensive evidence suggests that inflammation, in turn, initiates excitotoxicity, which is responsible for the majority of pathological findings in all stages of the disease, especially a loss of oligodendroglia (source of myelin) and axon injury in MS. Excitotoxicity also is a better explanation for progressive MS, in which the immune attack has either slowed or is halted; yet, the destructive pathology continues to progress. It also explains the destructive lesions seen in gray matter, which is essentially devoid of inflammation. It has recently been shown that most of the damage to the oligodendrocytes, as well as axonal injury, is secondary to excitotoxicity. While there is a growing appreciation that excitotoxicity plays a major role, there has been little effort to link the immune changes to the excitotoxic process, recently named immunoexcitotoxicity, even though the role of excitotoxicity has been shown to occur in the inflammatory stage in the beginning and throughout the process of the disease, particularly the chronic progressive stage. It is also known that peripheral glutamate receptors exist throughout the body, thus making the process of immunoexcitotoxicity a possible integral part of all or most autoimmune disorders in which the immune system is intimately linked to enhancing the excitotoxic process. This is of special concern now that peripheral glutamate receptors have been isolated in many peripheral tissues and are known to be fully functional.<\/jats:p>","DOI":"10.25259\/sni_1114_2024","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:35:01Z","timestamp":1738305301000},"page":"26","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders"],"prefix":"10.25259","volume":"16","author":[{"given":"Russell L.","family":"Blaylock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"10.25259\/SNI_1114_2024\/ref-1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00415-003-1041-0","article-title":"Nitric oxide as an activity marker in multiple sclerosis","volume":"250","author":"Acar","year":"2003","journal-title":"J Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/35094583","article-title":"Cytokines and acute neurodegeneration","volume":"2","author":"Allan","year":"2001","journal-title":"Nature Rev Neurosci"},{"key":"10.25259\/SNI_1114_2024\/ref-3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.autrev.2004.07.036","article-title":"Is autism an autoimmune disease?","volume":"3","author":"Ashwood","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.25259\/SNI_1114_2024\/ref-4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1212\/WNL.0b013e31822f04a0","article-title":"Circumventricular organs: Receptive and homeostatic functions and clinical implications","volume":"77","author":"Benarroch","year":"2011","journal-title":"Neurology"},{"key":"10.25259\/SNI_1114_2024\/ref-5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp.2008.148403","article-title":"Memory impairments in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy","volume":"80","author":"Benedict","year":"2009","journal-title":"J Neuro Neurosur Psychiatry"},{"key":"10.25259\/SNI_1114_2024\/ref-6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1474-4422(06)70349-0","article-title":"The measurement and clinical relevance of brain atrophy in multiple sclerosis","volume":"5","author":"Bermel","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-7","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1510-05.2005","article-title":"Modulator effects of interleukin-1\u00df and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures","volume":"25","author":"Bernardino","year":"2005","journal-title":"J Neurosci"},{"key":"10.25259\/SNI_1114_2024\/ref-8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/2152-7806.83391","article-title":"Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis","volume":"2","author":"Blaylock","year":"2011","journal-title":"Surg Neurol Int"},{"issue":"9","key":"10.25259\/SNI_1114_2024\/ref-9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/sni.sni_407_17","article-title":"Immunoexcitotocity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum","volume":"9","author":"Blaylock","year":"2018","journal-title":"Surg Neurol Int"},{"key":"10.25259\/SNI_1114_2024\/ref-10","first-page":"60","article-title":"A possible central mechanism in autism spectrum disorders, part 2: Immunoexcitotoxicity","volume":"15","author":"Blaylock","year":"2009","journal-title":"Altern Ther Health Med"},{"key":"10.25259\/SNI_1114_2024\/ref-11","first-page":"42","article-title":"Immunoexcitoxicity as a central mechanism of autism spectrum disorders","volume-title":"Cellular and molecular biology in autism spectrum disorders.","author":"Blaylock","year":"2010"},{"issue":"3","key":"10.25259\/SNI_1114_2024\/ref-12","first-page":"19","article-title":"Natural plant products and extracts that reduce immunoexcitoxicity-associated neurodegeneration and promote repair within the central nervous system","volume":"2","author":"Blaylock","year":"2011","journal-title":"Surg Neurol Inter"},{"key":"10.25259\/SNI_1114_2024\/ref-13","first-page":"10","article-title":"The central role of excitotoxicity in autism spectrum disorders","volume":"6","author":"Blaylock","year":"2003","journal-title":"JANA"},{"key":"10.25259\/SNI_1114_2024\/ref-14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.25259\/SNI_626_2023","article-title":"Why immunoexcitotoxicity is the basis of most neurodegenerative diseases and systemic immune activation: An analysis","volume":"14","author":"Blaylock","year":"2023","journal-title":"Surg Neurol Inter"},{"key":"10.25259\/SNI_1114_2024\/ref-15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"Bo","year":"2003","journal-title":"J Neuropath Exp Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: Activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.25259\/SNI_1114_2024\/ref-17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2013-203670","article-title":"AMPA\/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis","volume":"74","author":"Bonnet","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.25259\/SNI_1114_2024\/ref-18","doi-asserted-by":"crossref","first-page":"926688","DOI":"10.3389\/fpsyt.2022.926688","article-title":"The effect of the low glutamate diet on the reduction of psychiatric symptoms in veterans with gulf war illness: A pilot randomized-controlled trial","volume":"13","author":"Brandley","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.25259\/SNI_1114_2024\/ref-19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000126843","article-title":"Glutamate: A major excitatory transmitter in neuroendocrine regulation","volume":"61","author":"Brann","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.25259\/SNI_1114_2024\/ref-20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","article-title":"System xc\u207b cystine\/glutamate antiporter: An update on molecular pharmacology and roles within the CNS","volume":"165","author":"Bridges","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.25259\/SNI_1114_2024\/ref-21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0891-5849(02)01112-7","article-title":"Nitric oxide inhibition of mitochondrial respiration and its role in cell death","volume":"33","author":"Brown","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.25259\/SNI_1114_2024\/ref-22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis","volume":"97","author":"Bruce","year":"2021","journal-title":"Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","article-title":"Cortical lesions and atrophy associated with cognitive impairments in relapsing-remitting multiple sclerosis","volume":"66","author":"Calabrese","year":"2009","journal-title":"Arc Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrn3900","article-title":"Exploring the origins of grey matter damage in multiple sclerosis","volume":"16","author":"Calabrese","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.25259\/SNI_1114_2024\/ref-25","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.3390\/ijms23105347","article-title":"Acute colon inflammation triggers primary motor cortex glial activation, neuroinflammation, neuronal hyperexcitability, and motor coordination deficits","volume":"23","author":"Carrascal","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.25259\/SNI_1114_2024\/ref-26","doi-asserted-by":"crossref","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.25259\/SNI_1114_2024\/ref-27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.physbeh.2017.01.028","article-title":"A study of glutamate levels, NR1, NR2A, NR2B receptors and oxidative stress in rat model of Japanese encephalitis","volume":"171","author":"Chauhan","year":"2017","journal-title":"Physiol Behav"},{"key":"10.25259\/SNI_1114_2024\/ref-28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/glia.22282","article-title":"Glutamate released by Japanese encephalitis virus-infected microglia involves YNF-alpha signaling and contributes to neuronal death","volume":"60","author":"Chen","year":"2012","journal-title":"Glia"},{"key":"10.25259\/SNI_1114_2024\/ref-29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4103\/1673-5374.266047","article-title":"Glutamate receptors and glutamatergic signalling in the peripheral nerves","volume":"15","author":"Chen","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.25259\/SNI_1114_2024\/ref-30","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1523\/JNEUROSCI.19-22-09813.1999","article-title":"Neuronal death and blood-brain barrier breakdown after excitotoxic injury are independent processes","volume":"19","author":"Chen","year":"1999","journal-title":"J Neurosci"},{"key":"10.25259\/SNI_1114_2024\/ref-31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3349\/ymj.2008.49.1.1","article-title":"Role of brain inflammation in epileptogenesis","volume":"49","author":"Choi","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.25259\/SNI_1114_2024\/ref-32","first-page":"272","article-title":"Metabolite findings in tumefactive demyelinating lesions utilizing short echo time protein magnetic resonance spectroscopy","volume":"28","author":"Cianfoni","year":"2007","journal-title":"AJNR Am. J Neuroradiol"},{"key":"10.25259\/SNI_1114_2024\/ref-33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12974-016-0708-2","article-title":"Excess cerebral TNF causing glutamate excitoxicity rationalizes treatment of neurodegeneratiove diseases and neurogenic pain by anti-TNF-alpha agents","volume":"13","author":"Clark","year":"2016","journal-title":"J Neuroinflamm"},{"key":"10.25259\/SNI_1114_2024\/ref-34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/1352458514533230","article-title":"The role of microglial activation in disease progression","volume":"20","author":"Correale","year":"2014","journal-title":"Mult Scler"},{"key":"10.25259\/SNI_1114_2024\/ref-35","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.25259\/SNI_1114_2024\/ref-36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ebiom.2019.08.004","article-title":"NMDA receptor modulation of glutamate release in activated neutrophils","volume":"47","author":"Del Arroyo","year":"2019","journal-title":"EBioMedicine"},{"key":"10.25259\/SNI_1114_2024\/ref-37","first-page":"383","article-title":"Autoimmunity, autoantibodies, and autism spectrum disorders (ASD)","volume":"81","author":"Edminson","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.25259\/SNI_1114_2024\/ref-38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/brain\/awh323","article-title":"Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions","volume":"128","author":"Evangelou","year":"2005","journal-title":"Brain"},{"key":"10.25259\/SNI_1114_2024\/ref-39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.1401108","article-title":"Inhibition of system Xc(-) transporter attenuates autoimmune inflammatory demyelination","volume":"195","author":"Evonuk","year":"2015","journal-title":"J Immunol"},{"key":"10.25259\/SNI_1114_2024\/ref-40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awt110","article-title":"Disease-specific molecular events in cortical multiple sclerosis lesions","volume":"136","author":"Fischer","year":"2013","journal-title":"Brain"},{"key":"10.25259\/SNI_1114_2024\/ref-41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.21423","article-title":"Gray matter atrophy is related to long-term disability in multiple sclerosis","volume":"64","author":"Fisniku","year":"2008","journal-title":"Ann Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-42","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1111\/j.0959-9673.2004.0369x.x","article-title":"The role of glutamate signaling in rheumatoid arthritis","volume":"85","author":"Flood","year":"2004","journal-title":"Inter J Exper Path"},{"key":"10.25259\/SNI_1114_2024\/ref-43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05315.x","article-title":"Interleukin-1beta: A bridge between inflammation and excitotoxicity?","volume":"106","author":"Fogal","year":"2008","journal-title":"J Neurochem"},{"key":"10.25259\/SNI_1114_2024\/ref-44","doi-asserted-by":"crossref","first-page":"RC216","DOI":"10.1523\/JNEUROSCI.22-07-j0001.2002","article-title":"Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2","volume":"22","author":"Fontaine","year":"2002","journal-title":"J Neurosci"},{"key":"10.25259\/SNI_1114_2024\/ref-45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000111367","article-title":"Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor sub-type: Implications for AIDS neuropathogenesis","volume":"15","author":"Gelbard","year":"1993","journal-title":"Dev Neurosc"},{"key":"10.25259\/SNI_1114_2024\/ref-46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/iub.98","article-title":"Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia","volume":"60","author":"Grewer","year":"2008","journal-title":"IUBMB Life"},{"key":"10.25259\/SNI_1114_2024\/ref-47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000089622","article-title":"Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis","volume":"2","author":"Guillemin","year":"2005","journal-title":"Neurodegener Dis"},{"key":"10.25259\/SNI_1114_2024\/ref-48","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.joms.2009.04.056","article-title":"Endogenous glutamate in association with inflammatory and hormonal factors modulates bone tissue resorption of the tempomandibular joint in patients with early rheumatoid arthritis","volume":"67","author":"Hajati","year":"2009","journal-title":"J Maxillofac Surg"},{"key":"10.25259\/SNI_1114_2024\/ref-49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1033.2003.03907.x","article-title":"Glutamate signaling in peripheral tissues","volume":"271","author":"Hinoi","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.25259\/SNI_1114_2024\/ref-50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1254\/jphs.11R03CR","article-title":"Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis","volume":"116","author":"Hinoi","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.25259\/SNI_1114_2024\/ref-51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1096\/fasebj.9.8.7768362","article-title":"Expression and role of ionotropic glutamate receptors in pancreatic islet cells","volume":"9","author":"Inagaki","year":"1995","journal-title":"FASEB J"},{"key":"10.25259\/SNI_1114_2024\/ref-52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.22358","article-title":"Purnigeric receptors in microglia: Functional modal shifts of microglial mediated P2 and P1 receptors","volume":"61","author":"Koizumi","year":"2013","journal-title":"Glia"},{"key":"10.25259\/SNI_1114_2024\/ref-53","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1096\/fj.05-3748fje","article-title":"Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: A mechanism mediated by tumor necrosis factor-alpha","volume":"19","author":"Korn","year":"2005","journal-title":"FASEB J"},{"key":"10.25259\/SNI_1114_2024\/ref-54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/revneuro-2012-0062","article-title":"Multiple sclerosis and glutamate excitotoxicity","volume":"24","author":"Kostic","year":"2013","journal-title":"Rev Neurosci"},{"key":"10.25259\/SNI_1114_2024\/ref-55","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury un multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.25259\/SNI_1114_2024\/ref-56","first-page":"263","article-title":"Beatte EC","volume":"1","author":"Leonoudakis","year":"2004","journal-title":"TNF-alpha-induced AMPA-receptor trafficking in CNS neurons: relevance to excitotoxicity? Neuron Glia Biol"},{"key":"10.25259\/SNI_1114_2024\/ref-57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.25259\/SNI_1114_2024\/ref-58","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_1114_2024\/ref-59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/brain\/awp046","article-title":"Mitochondrial changes within axons in multiple sclerosis lesions","volume":"132","author":"Mahad","year":"2009","journal-title":"Brain"},{"key":"10.25259\/SNI_1114_2024\/ref-61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458518823940","article-title":"The role of infections in multiple sclerosis","volume":"25","author":"Marrodan","year":"2019","journal-title":"Multiple Sclerosis J"},{"key":"10.25259\/SNI_1114_2024\/ref-62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuint.2007.04.009","article-title":"The excitotoxic effect of NMDA on human lymphocyte immune function","volume":"51","author":"Mashkina","year":"2007","journal-title":"Neurochem Int"},{"key":"10.25259\/SNI_1114_2024\/ref-63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1740925X08000033","article-title":"Interaction between glutamate signaling and immune attack in damaging oligodendrocytes","volume":"3","author":"Matute","year":"2008","journal-title":"Neuron Glia Biol"},{"key":"10.25259\/SNI_1114_2024\/ref-64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm0398-291","article-title":"Oligodendrocytes from forebrain are highly vulnerable to AMPA\/kainate receptor-mediated excitotoxicity","volume":"4","author":"McDonald","year":"1998","journal-title":"Nat Med"},{"key":"10.25259\/SNI_1114_2024\/ref-65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2249.2004.02563.x","article-title":"Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies","volume":"137","author":"McNearney","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.25259\/SNI_1114_2024\/ref-66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/08916930500050277","article-title":"Infection, vaccines and other environmental triggers of autoimmunity","volume":"38","author":"Molina","year":"2005","journal-title":"Autoimmunity"},{"key":"10.25259\/SNI_1114_2024\/ref-67","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00018-008-8059-5","article-title":"Astrocytes in multiple sclerosis: a product of their environment","volume":"65","author":"Nair","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.25259\/SNI_1114_2024\/ref-68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-011-8287-6","article-title":"Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy","volume":"42","author":"Nakahara","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.25259\/SNI_1114_2024\/ref-69","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/npp.2016.185","article-title":"Microglial priming with aging and stress","volume":"42","author":"Niraula","year":"2017","journal-title":"Neuropsychopharmacolgy"},{"key":"10.25259\/SNI_1114_2024\/ref-70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res"},{"key":"10.25259\/SNI_1114_2024\/ref-71","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1007\/s00216-017-0486-4","article-title":"Urinary profiling of tryptophan and its related metabolites in patients with metabolic syndrome by liquid chromatographyelectrospray ionization\/mass spectrometry","volume":"409","author":"Oh","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"10.25259\/SNI_1114_2024\/ref-72","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.166.3903.386","article-title":"Brain lesions in an infant rhesus monkey treated with monosodium glutamate","volume":"166","author":"Olney","year":"1969","journal-title":"Science"},{"key":"10.25259\/SNI_1114_2024\/ref-73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tem.2015.12.004","article-title":"Exciting times for pancreatic islets: Glutamate signaling in endocrine cells","volume":"27","author":"Otter","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.25259\/SNI_1114_2024\/ref-74","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.4049\/jimmunol.177.10.6695","article-title":"Glutamate released by dendritic cells as a novel modulator of T cell activation","volume":"177","author":"Pacheco","year":"2006","journal-title":"J Immunol"},{"key":"10.25259\/SNI_1114_2024\/ref-75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/ars.2016.6715","article-title":"Blockage of glutamine synthetase enhances inflammatory response in microglial cells","volume":"26","author":"Palmieri","year":"2017","journal-title":"Antiox Redox Sig"},{"key":"10.25259\/SNI_1114_2024\/ref-76","doi-asserted-by":"crossref","first-page":"e918","DOI":"10.1038\/tp.2016.200","article-title":"Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation","volume":"6","author":"Parrott","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.25259\/SNI_1114_2024\/ref-77","first-page":"1","article-title":"Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"P\u00e9rez-De La Cruz","year":"2012","journal-title":"Int J Tryptophan Res"},{"key":"10.25259\/SNI_1114_2024\/ref-78","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.4049\/jimmunol.152.7.3578","article-title":"Involvement of the cystine transport system xc-in the macrophage-induced glutamate-dependent cytotoxicity to neurons","volume":"152","author":"Piani","year":"1994","journal-title":"J Immunol"},{"key":"10.25259\/SNI_1114_2024\/ref-79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(91)90559-C","article-title":"Murine brain macrophages induce NMDA receptor neurotoxicity in vitro by secreting glutamate","volume":"133","author":"Piani","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.25259\/SNI_1114_2024\/ref-80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1568007023339328","article-title":"The metabotropic glutamate receptors: Structure, activation mechanism and pharmacology","volume":"1","author":"Pin","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.25259\/SNI_1114_2024\/ref-81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat Med"},{"key":"10.25259\/SNI_1114_2024\/ref-82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/nyas.12841","article-title":"Pathological differences between white and grey matter multiple sclerosis lesions","volume":"1351","author":"Prins","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.25259\/SNI_1114_2024\/ref-83","doi-asserted-by":"crossref","first-page":"17151","DOI":"10.1073\/pnas.0806682105","article-title":"Microglial activation and TNF-alpha production mediate altered CNS excitability following peripheral inflammation","volume":"105","author":"Riazi","year":"2008","journal-title":"PNAS"},{"key":"10.25259\/SNI_1114_2024\/ref-84","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1212\/NXI.0000000000000443","article-title":"Microglial activation, white matter tract damage, and disability in MS","volume":"5","author":"Rissanen","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.25259\/SNI_1114_2024\/ref-85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.22512","article-title":"Interleukin-1\u00df causes synaptic hyperexcitability in multiple sclerosis","volume":"71","author":"Rossi","year":"2012","journal-title":"Ann Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-86","doi-asserted-by":"crossref","first-page":"100839","DOI":"10.1016\/j.bbih.2024.100839","article-title":"Does the kynurenine pathway play a pathogenic role in autism spectrum disorder?","volume":"40","author":"Santana-Coelho","year":"2024","journal-title":"Brain Behav Immun Health"},{"key":"10.25259\/SNI_1114_2024\/ref-87","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","article-title":"Excitatory amino acids and multiple sclerosis: Evidence from cerebrospinal fluid","volume":"60","author":"Sarchielli","year":"2003","journal-title":"Arch Neurol"},{"key":"10.25259\/SNI_1114_2024\/ref-88","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","article-title":"Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_1114_2024\/ref-89","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","article-title":"Onset of multiple sclerosis associated with anti-TNF therapy","volume":"57","author":"Sicotte","year":"2001","journal-title":"Neurology"},{"key":"10.25259\/SNI_1114_2024\/ref-90","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF03401690","article-title":"Inhibition of astrocyte glutamate uptake by reactive oxygen species: Role of antioxidant enzymes","volume":"3","author":"Sorg","year":"1997","journal-title":"Mol Med"},{"key":"10.25259\/SNI_1114_2024\/ref-91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0022-510X(96)00197-9","article-title":"Excess glutamate in the cerebrospinal fluid in bacterial meningitis","volume":"143","author":"Spranger","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.25259\/SNI_1114_2024\/ref-92","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00702-014-1188-0","article-title":"The role of glutamate and its receptors in multiple sclerosis","volume":"121","author":"Stojanovic","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"key":"10.25259\/SNI_1114_2024\/ref-93","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1365-2362.1997.2250774.x","article-title":"Neurotransmitters in cerebrospinal fluid reflect pathological activity","volume":"27","author":"Stover","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.25259\/SNI_1114_2024\/ref-94","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"Tavares","year":"2002","journal-title":"Neurochem Int"},{"key":"10.25259\/SNI_1114_2024\/ref-95","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0009-9120(98)00003-4","article-title":"Measurement of glutamine and glutamate by capillary electrophoresis and laser induced fluorescence detection in cerebrospinal fluid of meningitis sick children","volume":"31","author":"Tucci","year":"1998","journal-title":"Clin Biochem"},{"key":"10.25259\/SNI_1114_2024\/ref-96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2982.2009.01390.x","article-title":"N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat","volume":"22","author":"Varga","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.25259\/SNI_1114_2024\/ref-97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-6606-5-13","article-title":"Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity","volume":"5","author":"Wang","year":"2012","journal-title":"Mol Brain"},{"key":"10.25259\/SNI_1114_2024\/ref-98","doi-asserted-by":"crossref","first-page":"eadj6187","DOI":"10.1126\/sciadv.adj6187","article-title":"Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis","volume":"9","author":"Zhai","year":"2023","journal-title":"Sci Adv"},{"key":"10.25259\/SNI_1114_2024\/ref-99","doi-asserted-by":"crossref","first-page":"e0158688","DOI":"10.1371\/journal.pone.0158688","article-title":"Blood glutamate levels in autism spectrum disorder: A systematic review and meta-analysis","volume":"11","author":"Zheng","year":"2016","journal-title":"PLoS One"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/immunoexcitoxicity-as-the-possible-major-pathophysiology-behind-multiple-sclerosis-and-other-autoimmune-disorders\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/immunoexcitoxicity-as-the-possible-major-pathophysiology-behind-multiple-sclerosis-and-other-autoimmune-disorders\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:35:32Z","timestamp":1738305332000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/immunoexcitoxicity-as-the-possible-major-pathophysiology-behind-multiple-sclerosis-and-other-autoimmune-disorders\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":99,"alternative-id":["10.25259\/SNI_1114_2024"],"URL":"https:\/\/doi.org\/10.25259\/sni_1114_2024","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"26"}}